| 胸腺素辅助治疗耐多药肺结核34例 |
| |
| 引用本文： | 张望珍,陈明. 胸腺素辅助治疗耐多药肺结核34例[J]. 医药导报, 2004, 23(3): 0143-0144 |
| |
| 作者姓名： | 张望珍 陈明 |
| |
| 作者单位： | 武汉钢铁集团公司安全环保部职业病防治所,430080 |
| |
| 摘 要： | 目的：探讨耐多药结核病的治疗方法。方法： 将68例耐多药肺结核患者随机分为治疗组和对照组各34例。两组患者的化疗方案均为3AMIDZOE/6DEO，强化期3个月，继续期在痰菌阴转6个月后停药。治疗组在强化期加用胸腺素100 mg加入0.9%氯化钠注射液100 mL，静脉滴注，qd，4周后，改为每周3次，连用4周。结果： 治疗组6，9个月痰菌阴转率均为76.5%，明显高于对照组(50.0%，47.1%)，二者差异有显著性(P＜0.05)；治疗组空洞闭合率78.2%，明显高于对照组(50.0%)(P＜0.05)。结论： 胸腺素辅助治疗耐多药肺结核疗效显著。
|
| 关 键 词： | 胸腺素 肺结核 耐药性 |
| 文章编号： | 1004-0781(2004)03-0143-02 |
| 修稿时间： | 2003-11-06 |
Clinical Controlled Study on Efficacy of Thymosin in Treatment of Multidrug Resistant Pulmonary Tuberculosis |
| |
| ZHANG Wang-zhen,CHEN Min. Clinical Controlled Study on Efficacy of Thymosin in Treatment of Multidrug Resistant Pulmonary Tuberculosis[J]. Herald of Medicine, 2004, 23(3): 0143-0144 |
| |
| Authors: | ZHANG Wang-zhen CHEN Min |
| |
| Abstract: | Objective:To explore the effect of thymosin in the treatment of multidrug resistance (MTB) pulmonary tuberculosis. Methods:Sixty-eight suitable patients were randomized into two groups: the treatment and the control with 34 cases in each group. Both groups received the same chemotherapy scenario: 3AMIDZOE/6DEO, strengthening treatment for 3 months, succeeding treatment for 6 months after the negative result of sputum examination for tubercle bacillus. The treatment group also received thymosin 100 mg dissolved in 250 mL sodium chloride injection by intravenous infusion daily in succeeding period. Results: Negative conversions in treatment group for 6 months, 9 months were both 76.5%, significantly higher than 50.0%, 47.1% in control group (P<0.05). The rate of closed cavity was 78.2% in the former also significantly higher than 50.0% (P<0.05) in the latter. Conclusions:Thymosin in treatment MDR pulmonary tuberculosis is obvious effect. |
| |
| Keywords: | Thymosin Tuberculosis pulmonary Multidrug resistance |
| 本文献已被 CNKI 万方数据 等数据库收录！ |
| 点击此处可从《医药导报》浏览原始摘要信息 |
|
点击此处可从《医药导报》下载全文 |
